World Health Organization
[용어속성] Institution
Impact of COVID-19 acute respiratory disease on the risk factors attributed to cancer patients
Regular Article
[키워드] AACR, American Association of Cancer Research
AACRAmerican Association of Cancer Research
Abstract
acute respiratory disease
acute respiratory syndrome
Affect
American Association of Cancer Research
American Society of Clinical Oncology
ARD
article
ASCO, American Society of Clinical Oncology
ASCOAmerican Society of Clinical Oncology
Cancer
cancer patient
Cancer patients
cancer treatment
Care
cause
CCC-19, COVID-19 and Cancer Consortium
CCC-19COVID-19 and Cancer Consortium
CDs, Communicable diseases
CDsCommunicable diseases
clinical
communicable disease
communicable diseases
condition
conducted
coronavirus
Coronavirus disease 2019
Coverage
COVID-19
COVID-19 and Cancer Consortium
COVID-19 ARD, acute respiratory disease
COVID-19 ARDacute respiratory disease
COVID-19, Coronavirus disease 2019
COVID-19coronavirus disease 2019
creating
death
decrease
Direct
Effect
Elsevier
ESCA, Esophageal carcinoma
ESCAEsophageal carcinoma
ESMO, European Society for Medical Oncology
ESMOEuropean Society for Medical Oncology
Esophageal carcinoma
European Society for Medical Oncology
feature
Francis
Google Scholar
Health
healthy
ICU, Intensive care unit
ICUIntensive Care Unit
Impact
intensive care unit
KICH, Kidney Chromophobe
KICHKidney Chromophobe
Kidney Chromophobe
Kidney renal papillary cell carcinoma
KIRP, Kidney renal papillary cell carcinoma
KIRPKidney renal papillary cell carcinoma
LUAD, Lung adenocarcinoma
LUADLung adenocarcinoma
lung adenocarcinoma
notable
pandemic
Patient
PCR, Real-time Polymerase Chain Reaction
PCRReal-time Polymerase Chain Reaction
PRAD, Prostate adenocarcinoma
PRADProstate adenocarcinoma
problem
prostate adenocarcinoma
real-time polymerase chain reaction
reported
Research
Result
retrieved
risk factor
Risk factors
SARS-CoV-2
SARS-CoV-2 virus
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
Science
severe acute respiratory syndrome coronavirus 2
severe complication
Taylor
the disease
transfer
Transmission
Treatment
UCEC, Uterine Corpus Endometrial Carcinoma
UCECUterine Corpus Endometrial Carcinoma
Uterine Corpus Endometrial Carcinoma
vaccination
were used
WHO, World Health Organization
WHOWorld Health Organization
World Health Organization
[DOI] 10.1016/j.toxrep.2021.12.004 PMC 바로가기 [Article Type] Regular Article
[DOI] 10.1016/j.toxrep.2021.12.004 PMC 바로가기 [Article Type] Regular Article
Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study
국제 전향 코호트 연구에서 SARS-CoV-2 감염 후 길랭-바레 증후군
Observational Study
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
age-matched control
Background Prevalence
Campylobacter jejuni
Case report
case reports
case-control study
clinical phenotype
Control
coronavirus
COVID-19
described
determine
disease course
eight
estimate
European
evidence of
facial
facial palsy
Features
Frequency
Guillain-Barré
Guillain-barrè syndrome
had no
Health Organization
Infection
International
interquartile range
Laboratory
median time
neurological
Neurological disorders
Neurological symptom
Neurological symptoms
no increase
palsy
pandemic
Patient
patient recruitment
patients
preceding infections
prevalent
prevention
Prevention and control
Previous studies
prospective cohort study
prospective observational cohort
recommendation
recruitment
recruitment bia
recruitment bias
reported
required
retrospective cohort
SARS-CoV-2
SARS-COV-2 infection
serological evidence
severe acute respiratory syndrome Coronavirus
study population
subject
syndrome
the SARS-CoV-2
unlikely
variant
wake
weakness
were used
World Health Organization
[DOI] 10.1093/brain/awab279 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1093/brain/awab279 PMC 바로가기 [Article Type] Observational Study
Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma
Perspective
[키워드] Affect
affected
Area
both sexes
boys
Cancer
Control
country
Coverage
COVID-19
European
expert
extension
Factors
gender-neutral
group
Guidance
HPV
HPV vaccination
HPV vaccine
Human
human papillomavirus
introduced
National
predicted
prevention
recommendation
shortage
temporary
vaccination
Vaccines
while
WHO
World Health Organization
[DOI] 10.2807/1560-7917.ES.2021.26.50.2001659 PMC 바로가기 [Article Type] Perspective
[DOI] 10.2807/1560-7917.ES.2021.26.50.2001659 PMC 바로가기 [Article Type] Perspective
SARS‐CoV‐2 Omicron variant: Characteristics and prevention
Perspective
[키워드] accumulated
ACE2
acute respiratory syndrome
B.1.1.529
Beta
Characteristics
coronavirus
Coronavirus disease 2019
COVID‐19
delta variant
described
enzyme
FIVE
Gamma
global public health
immune evasion
L452R
Mutation
mutations
omicron
overcome
pathogenicity
Prevalence
Prevent
raised
rapid increase
RBD
receptor
receptor‐binding domain
reported
residue
SARS‐CoV‐2
South Africa
substitutions
T478K
the RBD
Transmissibility
variant
variants
VoC
VOCs
WHO
World Health Organization
[DOI] 10.1002/mco2.110 PMC 바로가기 [Article Type] Perspective
[DOI] 10.1002/mco2.110 PMC 바로가기 [Article Type] Perspective
Suspend or amend? Randomized controlled trial on neuropsychological rehabilitation for epilepsy: A COVID-19 impact
Research article
[키워드] analysed
approved
Biostatistics Working Party
BSWPBiostatistics Working Party
caused
Clinical Trials Registry of India
Controlled trial
COVID-19
CTRIClinical Trials Registry of India
DREDrug Resistant Epilepsy
Drug resistant epilepsy
drug-resistant
Effect
Effectiveness
epilepsy
FGDsFocus Group Discussions
Focus Group Discussions
Health Insurance Portability and Accountability Act
HIPPAHealth Insurance Portability and Accountability Act
ILAEInternational League Against Epilepsy
Impact
implication
India
INSInternational Neuropsychological Society
International League Against Epilepsy
International Neuropsychological Society
LBTLumosity Brain Training
Lumosity Brain Training
Modification
National Institutes of Health
NIHNational Institutes of Health
pandemic
Patient
Randomized controlled trial
Randomized controlled trials
RCTsrandomized controlled trials
rehabilitation
Research
Result
Tele-neuropsychology
TeleNPTele-Neuropsychology
TMTTraditional Memory Training
Traditional Memory Training
Trial
WHOWorld Health Organization
World Health Organization
[DOI] 10.1016/j.ebr.2021.100516 [Article Type] Research article
[DOI] 10.1016/j.ebr.2021.100516 [Article Type] Research article
Classification of COVID-19 and Pneumonia Using Deep Transfer Learning
심층 전이 학습을 사용한 코로나19 및 폐렴 분류
Research Article
[키워드] Accuracy
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
affected
age
best
caused
children
China
classification
CNN
Contact
contagious
Convolutional neural network
Coronavirus-2
COVID-19
CXR
deep
detect
disease
effective
Features
global pandemic
globe
Health
Health Organization
health problems
immune system
immune systems
individual
infected with COVID-19
learning
life-threatening
Pneumonia
Precision
problem
referred to
Research
respiratory
SARS-CoV-2
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severity
subject
threshold
transfer
virus
was used
were used
WHO
World Health Organization
[DOI] 10.1155/2021/3514821 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2021/3514821 PMC 바로가기 [Article Type] Research Article
African countries established COVID-19 testing in one month: Here’s how they did it
Lessons from the Field
[키워드] acute respiratory syndrome
Africa
African
build
CDC
China
Control
coordinator
coronavirus
coronavirus disease
country
COVID-19
COVID-19 testing
Critical
demonstrated
Donor
Effectiveness
foundation
group
IMPROVE
Jack Ma
Laboratory
lesson
Local
molecular test
pandemic
prevention
public health
resource
responsible
secure
sequence
Spread
testing capacity
the disease
the SARS-CoV-2 genome
World Health Organization
[DOI] 10.4102/ajlm.v10i1.1457 PMC 바로가기 [Article Type] Lessons from the Field
[DOI] 10.4102/ajlm.v10i1.1457 PMC 바로가기 [Article Type] Lessons from the Field
The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
SARS-CoV-2의 오미크론 변종: 알려진 것에 대한 이해와 미지의 삶
Commentary
[키워드] country
COVID‐19
Health Organization
knowledge
mutations
omicron
Omicron variant
pandemic
provide
public health
question
SARS‐CoV‐2
understanding
variant
Viral
viral variant
virus
widespread
World Health Organization
[DOI] 10.1002/ctm2.685 PMC 바로가기 [Article Type] Commentary
[DOI] 10.1002/ctm2.685 PMC 바로가기 [Article Type] Commentary
Strengthening the WHO in the pandemic era by removing a persistent structural defect in financing
Debate
[키워드] assessment
communicable diseases
country
COVID-19 pandemic
donors
expenditures
feature
financing
FIVE
fraction
functions
global health
Health
healthcare reform
include
International Health Regulations
lack
limitations
magnitude
measure
mechanism
overcome
pandemic era
Pandemics
performed
Perspective
recommendations
Removing
shielding
stability
supplementary material
Support
target
the WHO
to define
WHO
WHO’
World Health Organization
[DOI] 10.1186/s12992-021-00780-7 PMC 바로가기 [Article Type] Debate
[DOI] 10.1186/s12992-021-00780-7 PMC 바로가기 [Article Type] Debate